Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib

Update Il y a 4 ans
Reference: NCT01564836

Woman and Man

Extract

This prospective study is performed to identify safer and more concrete indicators of successful discontinuation and explore contributing factors for sustained undetectable transcript


Inclusion criteria

  • Chronic myeloid leukemia ,Imatinib ,Complete Molecular Response

Links